Latest Morning Briefing Stories

The Year in Opioid Settlements: 5 Things You Need to Know

In the past year, opioid settlement money has gone from an emerging funding stream for which people had lofty but uncertain aspirations to a coveted pot of billions being invested in remediation efforts. Here are some important and evolving factors to watch going forward.

‘They See a Cash Cow’: Corporations Could Consume $50 Billion of Opioid Settlements

As opioid settlement dollars land in government coffers, a swarm of businesses are positioning themselves to profit from the windfall. But will their potential gains come at the expense of the settlements’ intended purpose — to remediate the effects of the opioid epidemic?

KFF Health News' 'What the Health?': Abortion and SCOTUS, Together Again

The Supreme Court agreed this week to hear its first major case on abortion since overturning Roe v. Wade — one that could restrict the availability of the abortion pill mifepristone, even in states where abortion remains legal. Meanwhile, on Capitol Hill, lawmakers in the House and Senate finally moved to renew health programs that expired in October — but it’s likely too late to finish the job in 2023. Alice Miranda Ollstein of Politico, Riley Griffin of Bloomberg News, and Lauren Weber of The Washington Post join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Jen Golbeck, a University of Maryland professor and social media superstar, about her new book, “The Purest Bond,” which lays out the science of the human-canine relationship.

Rift Over When to Use N95s Puts Health Workers at Risk Again

The Centers for Disease Control and Prevention is considering fuzzy guidelines on infection control in hospitals, critics say, leaving employers free to cut corners on N95 masks and other protective measures.